Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

CFR Boss Asked About “New World Order”

The president of the globalist Council on Foreign Relations…
Read more

U.S. Stands with Israel

The United States took a stand for Israel in light of the…
Read more

National Surveillance Camera Rollout

A network of  security cameras by the name of TALON was…
Read more